Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2568770rdf:typepubmed:Citationlld:pubmed
pubmed-article:2568770lifeskim:mentionsumls-concept:C0312740lld:lifeskim
pubmed-article:2568770lifeskim:mentionsumls-concept:C0022687lld:lifeskim
pubmed-article:2568770lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2568770lifeskim:mentionsumls-concept:C0231204lld:lifeskim
pubmed-article:2568770lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2568770lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:2568770pubmed:issue2lld:pubmed
pubmed-article:2568770pubmed:dateCreated1989-8-16lld:pubmed
pubmed-article:2568770pubmed:abstractTextThe specificities and surface markers of murine autocytotoxic cells induced by in vitro culture with interleukin 2 (IL2) were studied. Culturing murine spleen cells with recombinant human IL2 resulted in the generation of cytotoxic cells which killed syngeneic lymphoblasts and syngeneic activated macrophages (M phi). Both lectins and protein antigens were capable of inducing lymphoblasts recognized by lymphokine-activated killer (LAK) cells. B-lymphoblasts as well as T-lymphoblasts were sensitive to lysis by these effector cells. In addition, peritoneal M phi activated in vivo with Bacille Calmette-Guérin (BCB), Corynebacterium parvum (C. parvum), thioglycollate (TG) or lipopolysaccharide (LPS) were shown to be susceptible to lysis by LAK cells. In contrast, neither unstimulated T cells nor resident peritoneal M phi were sensitive to lysis by LAK cells, suggesting that normal cells have to be activated in order to be sensitive to lysis by these effector cells. Surface marker analysis indicated that majority of effector cells which killed syngeneic lymphoblasts and activated M phi were Thy1+, asialo GM1+, L3T4-, Ly2-.lld:pubmed
pubmed-article:2568770pubmed:languageenglld:pubmed
pubmed-article:2568770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:citationSubsetIMlld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568770pubmed:statusMEDLINElld:pubmed
pubmed-article:2568770pubmed:issn0250-7005lld:pubmed
pubmed-article:2568770pubmed:authorpubmed-author:SuzukiHHlld:pubmed
pubmed-article:2568770pubmed:authorpubmed-author:YanoSSlld:pubmed
pubmed-article:2568770pubmed:authorpubmed-author:HoshinoKKlld:pubmed
pubmed-article:2568770pubmed:authorpubmed-author:KamitaniTTlld:pubmed
pubmed-article:2568770pubmed:authorpubmed-author:IkemotoMMlld:pubmed
pubmed-article:2568770pubmed:issnTypePrintlld:pubmed
pubmed-article:2568770pubmed:volume9lld:pubmed
pubmed-article:2568770pubmed:ownerNLMlld:pubmed
pubmed-article:2568770pubmed:authorsCompleteYlld:pubmed
pubmed-article:2568770pubmed:pagination293-7lld:pubmed
pubmed-article:2568770pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:meshHeadingpubmed-meshheading:2568770-...lld:pubmed
pubmed-article:2568770pubmed:articleTitleAutocytotoxic activity of lymphokine-activated killer cells: characterization of effector cells and susceptible targets.lld:pubmed
pubmed-article:2568770pubmed:affiliationFirst Department of Internal Medicine, Toyama Medical and Pharmaceutical University, School of Medicine, Japan.lld:pubmed
pubmed-article:2568770pubmed:publicationTypeJournal Articlelld:pubmed